应用微超声检测临床显著索引前列腺癌:与根治性前列腺切除术的病理相关性
回顾性分析25例接受活检及微超声评估后行根治性前列腺切除术的患者,由经验丰富的放射科医生盲法回顾微超声动态影像并赋予PRI-MUS评分。微超声对临床显著索引病灶(GG≥2)的患者水平检出率为87%(20/23),所有识别病灶PRI-MUS评分均为4或5分,外周带索引病灶检出率100%。
要点
- 微超声对临床显著索引病灶的患者水平检出率为87%(20/23)。
- 所有被微超声识别的病灶PRI-MUS评分均为4或5分。
- 3个漏诊索引病灶均位于移行带,外周带索引病灶检出率100%。
核心结论
- 微超声在检测前列腺索引病灶方面显示出高敏感度(87%),并识别出100%的外周带索引病灶。
研究设计与样本
- 回顾性纳入接受活检和微超声评估后行根治性前列腺切除术的男性患者,共25例。
- 由经验丰富的放射科医生回顾微超声动态影像,医生知晓患者已行根治性前列腺切除术但对病理数据设盲。
- 对可疑部位赋予PRI-MUS评分,根治性前列腺切除标本采用quarter mount技术检查。
- 在患者水平评估微超声对临床显著索引病灶(GG≥2)的检出率。
主要发现
- 25例中位年龄65.5岁(范围56-74),中位PSA 6.45 ng/dL(范围2-31.72)。
- 25例中2例根治性前列腺切除标本无临床显著前列腺癌(GG1病变)。
- 微超声可视化23个临床显著索引病灶中的20个(87%),中位长度9 mm(范围1.5-28.5)。
- 所有识别病灶均归类为PRI-MUS评分4或5分;3个漏诊索引病灶位于移行带,中位长度10.5 mm(范围4.5-22.5)。
- 微超声漏诊9例患者中的11个非索引临床显著前列腺癌病灶,中位长度1.5 mm(范围1.5-10.5),其中8个GG2、2个GG3、1个GG5;微超声识别出这9例患者全部临床显著索引病灶。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the detection of clinically significant prostate cancer (csPCa) index lesion using high resolution transrectal micro-ultrasound (MicroUS) applying PRI-MUS (Prostate Risk Identification using Micro Ultrasound) score v1.0. METHODS: Men who underwent radical prostatectomy following biopsy and MicroUS assessment were included. MicroUS dynamic cine loops of these patients were retrospectively reviewed by an experienced radiologist. The radiologist was aware that patients had undergone radical prostatectomy but was blinded to pathological data. Suspicious sites were assigned a PRI-MUS score. Radical prostatectomy specimens were examined with the quarter mount technique. Detection rate of csPCa index lesion [Grade Group (GG) ≥2] by MicroUS was assessed at a patient level. RESULTS: Twenty-five participants were included in the analysis. The median age was 65.5 years (range 56-74). Median PSA was 6.45 ng/dL (range 2-31.72). Two of 25 patients did not have csPCa (GG1 disease) on radical prostatectomy. MicroUS visualized 20/23 (87%) of the csPCa index lesions [median length 9 mm (range 1.5- 28.5)]. All identified lesions were categorized PRIMUS score 4 or 5. The 3 missed index lesions were in the transition zone [median length 10.5 mm (range 4.5-22.5)]. MicroUS missed 11 non index csPCa in 9 participants [median length 1.5 mm (range 1.5-10.5)]. Of these, 8 were GG2, 2 GG3 and 1 GG5. MicroUS identified the csPCa index lesion in all 9 of these men. CONCLUSION: MicroUS showed the high sensitivity (87%) in detecting index lesions in the prostate gland and identified 100% of index lesions in the peripheral zone.
引用
- Callejas MF, Klein EA, Truong M, et al. Detection of Clinically Significant Index Prostate Cancer Using Micro-ultrasound: Correlation With Radical Prostatectomy. Urology. 2022. PMID: 35843353. doi:10.1016/j.urology.2022.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。